Category: Media Coverage

Note: When you click on media articles below a new page will open indicating that you are leaving the Genprex Inc. Website and entering a third-party web site not affiliated with Genprex Inc. Or any of its affiliates. No information contained in a linked site has been endorsed or approved by Genprex Inc. And Genprex Inc. Is not responsible for the content of such third-party website.

How Genprex took an abandoned pipeline drug and turned it into Oncoprex, an innovative treatment for non-small cell lung cancer

The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual.

Read More

How gene therapy is reprogramming the course of lung cancer

How gene therapy is reprogramming the course of lung cancer

Read More

IPO alert: Cancer-fighting startup Genprex raises millions going public to fund new treatments

Lead product, Oncoprex, is an injectable treatment for lung cancer

Read More

SPORE Grants Turn Into Hope for Patients

SPORE Grants Turn Into Hope for Patients

Read More